Search research articles
Contact Us
Filters
Showing results (71-80 of 135) with videos related to
Page
of 14
Sort By:
The International Journal of Cardiovascular Imaging
|
June 2, 2007
Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus
Ren Kawaguchi, Manel Sabate, Dominick J Angiolillo, et al.
International Journal of Cardiology
|
September 8, 2009
Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary intervention
José Luis Ferreiro, Joan Antoni Gómez-Hospital, Ángel R Cequier, et al.
Thrombosis and Haemostasis
|
January 25, 2008
Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study
Dominick J Angiolillo, Esther Bernardo, Jorge Palazuelos, et al.
International Journal of Cardiology
|
January 18, 2008
Variable histological and ultrasonic characteristics of restenosis after drug-eluting stents
Nobuaki Suzuki, Dominick J Angiolillo, Carmela Monteiro, et al.
JACC. Cardiovascular Interventions
|
August 20, 2011
Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel
Masafumi Ueno, José L Ferreiro, Salvatore D Tomasello, et al.
JACC. Cardiovascular Interventions
|
March 24, 2012
Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study
Masafumi Ueno, José Luis Ferreiro, Bhaloo Desai, et al.
Thrombosis and Haemostasis
|
July 26, 2013
Impact of aspirin dose on adenosine diphosphate-mediated platelet activities. Results of an in vitro pilot investigation
Antonio Tello-Montoliu, Estela Thano, Fabiana Rollini, et al.
Circulation
|
October 12, 2020
Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS-6 Study
Francesco Franchi, Fabiana Rollini, Latonya Been, et al.
Journal of the American College of Cardiology
|
September 17, 2011
Impact of gastric acid-suppressing therapies on platelet reactivity in patients with coronary artery disease treated with clopidogrel: results of a pharmacodynamic study
John-Paul Pham, Masafumi Ueno, Antonio Tello-Montoliu, et al.
Thrombosis and Haemostasis
|
August 5, 2016
Impact of timing from blood sampling to pharmacodynamic assessment on measures of platelet reactivity in patients treated with P2Y<sub>12</sub> receptor inhibitors
Fabiana Rollini, Francesco Franchi, Kamaldeep Singh, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 135) with videos related to
Sort By:
Page
of 14
The International Journal of Cardiovascular Imaging
|
June 2, 2007
Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus
Ren Kawaguchi, Manel Sabate, Dominick J Angiolillo, et al.
International Journal of Cardiology
|
September 8, 2009
Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary intervention
José Luis Ferreiro, Joan Antoni Gómez-Hospital, Ángel R Cequier, et al.
Thrombosis and Haemostasis
|
January 25, 2008
Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study
Dominick J Angiolillo, Esther Bernardo, Jorge Palazuelos, et al.
International Journal of Cardiology
|
January 18, 2008
Variable histological and ultrasonic characteristics of restenosis after drug-eluting stents
Nobuaki Suzuki, Dominick J Angiolillo, Carmela Monteiro, et al.
JACC. Cardiovascular Interventions
|
August 20, 2011
Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel
Masafumi Ueno, José L Ferreiro, Salvatore D Tomasello, et al.
JACC. Cardiovascular Interventions
|
March 24, 2012
Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study
Masafumi Ueno, José Luis Ferreiro, Bhaloo Desai, et al.
Thrombosis and Haemostasis
|
July 26, 2013
Impact of aspirin dose on adenosine diphosphate-mediated platelet activities. Results of an in vitro pilot investigation
Antonio Tello-Montoliu, Estela Thano, Fabiana Rollini, et al.
Circulation
|
October 12, 2020
Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS-6 Study
Francesco Franchi, Fabiana Rollini, Latonya Been, et al.
Journal of the American College of Cardiology
|
September 17, 2011
Impact of gastric acid-suppressing therapies on platelet reactivity in patients with coronary artery disease treated with clopidogrel: results of a pharmacodynamic study
John-Paul Pham, Masafumi Ueno, Antonio Tello-Montoliu, et al.
Thrombosis and Haemostasis
|
August 5, 2016
Impact of timing from blood sampling to pharmacodynamic assessment on measures of platelet reactivity in patients treated with P2Y<sub>12</sub> receptor inhibitors
Fabiana Rollini, Francesco Franchi, Kamaldeep Singh, et al.
Page
of 14